📈 நேரலை சந்தை கண்காணிப்பு

NSE மற்றும் BSE-யின் ஒவ்வொரு கார்ப்பரேட் அறிவிப்பும், AI-யால் சில நிமிடங்களில் படிக்கப்பட்டு விளக்கப்படுகிறது — தாக்கம், முக்கிய புள்ளிவிவரங்கள், குறுகிய/நீண்டகாலப் பார்வை, கவனிக்க வேண்டியவை.

நேரலை இன்று 79 பகுப்பாய்வு செய்யப்பட்டது
பின்தொடர்Telegram
79
இன்று
168,780
இதுவரை பகுப்பாய்வு செய்யப்பட்டவை
49,911
நேர்மறை
8,497
எதிர்மறை
100,571
நடுநிலை
9,733
கண்காணி
குறிப்பு: இவை NSE பொது அறிக்கைகளின் AI-உருவாக்கிய, கல்வி நோக்கச் சுருக்கங்கள் — ஒவ்வொரு ஆவணத்தையும் ஆதாரமாகக் கொண்டவை, ஆனால் முதலீட்டு ஆலோசனை அல்ல, மேலும் முழுமையற்றதாகவும் இருக்கலாம். அசல் அறிக்கையுடன் சரிபார்க்கவும், செயல்படுவதற்கு முன் SEBI-பதிவு பெற்ற முதலீட்டு ஆலோசகரை அணுகவும்.
அழி
213 அறிவிப்புகள் பொருந்தும் தாக்கம் 5+ Symbol: TAC
நேர்மறை தாக்கம் 6/10 சட்டம்

CreditAccess Grameen Wins Income Tax Appeal; ₹46.03 Crore Demand Deleted

CreditAccess Grameen Limited has received a favorable ruling from the Commissioner of Income-tax (Appeals) regarding a tax dispute for Assessment Year 2022-23. The order, dated December 24, 2025, allows the company's appeal and completely deletes the previously issued demand of ₹46.03 crore. This resolution effectively removes a significant contingent liability that had been pending since March 2024. The decision by the National Faceless Appeal Centre provides financial clarity and eliminates the risk of a major cash outflow related to this specific tax matter.

நேர்மறை தாக்கம் 7/10 நிதி திரட்டல்

CreditAccess Grameen Allots USD 30 Million Non-Convertible Bonds to BlueOrchard

CreditAccess Grameen has successfully allotted 3,000 USD-denominated Non-Convertible Bonds (NCBs) to BlueOrchard Microfinance Fund on a private placement basis. The total fundraise amounts to USD 30 million with a face value of USD 10,000 per bond. These secured bonds carry a coupon rate of 240 basis points over Term SOFR and have a five-year tenure maturing in December 2030. This move helps the company diversify its funding sources and secure long-term capital for its microfinance operations.

நேர்மறை தாக்கம் 8/10 M&A

Tata Chemicals to Acquire Singapore's Novabay for EUR 25 Million to Boost Specialty Bicarb Portfolio

Tata Chemicals' subsidiary, TCIPL, has signed a deal to acquire 100% of Novabay Pte. Limited for an enterprise value of EUR 25 million (~SGD 37.8 million). Novabay is a Singapore-based manufacturer of premium-grade sodium bicarbonate with a 60,000-ton capacity, serving high-margin sectors like Pharma and Food. This strategic move aims to shift the company's mix toward non-cyclical, high-value products. The acquisition is expected to be completed by March 2026 and offers a clear path to expand capacity to 100,000 tons.

நடுநிலை தாக்கம் 7/10 நிதி திரட்டல்

Tata Chemicals Allots ₹1,500 Crore NCDs at 7.06% Coupon Rate

Tata Chemicals has successfully completed the allotment of 1,50,000 Non-Convertible Debentures (NCDs) to raise ₹1,500 crore on a private placement basis. These unsecured, rated debentures carry a fixed coupon rate of 7.06% per annum, which is competitive for the current market. The instruments have a tenor of 2 years and 364 days and will be listed on the NSE Debt Segment. This move strengthens the company's liquidity position and likely supports refinancing or general corporate purposes.

நடுநிலை தாக்கம் 7/10 நிதி முடிவுகள்

Tata Capital Q2 FY26 Standalone PAT at ₹661 Cr; Resubmits Legible Financial Results

Tata Capital Limited re-submitted its financial results for the quarter and half-year ended September 30, 2025, following a request from the NSE for a machine-readable copy. The company reported a standalone profit after tax (PAT) of ₹660.61 crore for Q2 FY26, a 6.5% decrease compared to ₹707.05 crore in Q2 FY25. Total revenue from operations grew slightly to ₹5,584.44 crore from ₹5,427.51 crore year-on-year. Asset quality showed some deterioration, with Gross NPA rising to 2.89% from 2.20% in the previous year.

📊 கடந்த 7 நாட்கள் — உணர்வு அடிப்படையில் பகுப்பாய்வு செய்யப்பட்ட அறிவிப்புகள்

நேர்மறைஎதிர்மறைநடுநிலைகவனம்
நடுநிலை தாக்கம் 7/10 நிதி திரட்டல்

Tata Chemicals to Raise ₹1,500 Crore via Private Placement of NCDs

Tata Chemicals has finalized the terms for raising ₹1,500 crore through the issuance of 1,50,000 unsecured Non-Convertible Debentures (NCDs). These NCDs, with a face value of ₹1,00,000 each, will be issued on a private placement basis and listed on the NSE debt segment. The tenure is fixed at 2 years and 364 days with a bullet repayment at maturity. The issue has been assigned a high credit rating of 'AA+/Stable' by both CARE and CRISIL, reflecting strong financial stability.

நடுநிலை தாக்கம் 6/10 நிதி திரட்டல்

CreditAccess Grameen to Issue Bonds & Debentures up to ₹1500 Crore

CreditAccess Grameen Limited's board has approved the issuance of foreign currency bonds and non-convertible debentures on a private placement basis. The fundraising includes various types of bonds and debentures, both listed and unlisted, secured and unsecured. The aggregate limit for the issuance is set at ₹1500,00,00,000 (₹1500 Crore). These securities will be issued in one or more tranches or series, offering flexibility in raising capital from domestic and foreign markets.

நேர்மறை தாக்கம் 7/10 நிதி திரட்டல்

CreditAccess Grameen Board Approves Fundraising of ₹1,500 Crores via Bonds and NCDs

CreditAccess Grameen Limited's Board has approved the issuance of foreign currency bonds and non-convertible debentures (NCDs) up to an aggregate limit of ₹1,500 Crores. The fundraising will be conducted through private placements in one or more tranches, targeting both domestic and international markets. The instruments may include subordinated, fixed rate, floating rate, and zero-coupon securities. This capital raise is intended to support the company's lending operations and diversify its funding sources.

நடுநிலை தாக்கம் 5/10 ஒழுங்குமுறை

CRISIL assigns/re-affirms Tata Chemicals' credit ratings

CRISIL has assigned a 'Crisil AA+/ Stable' rating to Tata Chemicals' ₹1,200 crore Non-Convertible Debentures (NCDs). It has also re-affirmed the 'Crisil AA+/ Stable' rating for ₹1,700 crore NCDs and 'Crisil A1+' rating for ₹300 crore Commercial Paper. These ratings indicate a stable outlook for the company's debt instruments. Investors should note these ratings as they reflect the creditworthiness of Tata Chemicals.

நேர்மறை தாக்கம் 8/10 வழக்கமானது

Tata Capital Reports USD 28Bn AUM and 1.1% NNPA in Post-Listing Business Update

Tata Capital Limited (TCL) has released a comprehensive business overview following its October 2025 listing and the merger with Tata Motors Finance. As of September 2025, the company manages an AUM of USD 28 billion, with a strategic focus on Retail and SME segments which comprise 88% of the portfolio. The company reported a strong H1 FY26 PAT of USD 237 million and maintains superior asset quality with a Net NPA of 1.1%. Backed by a 78.8% stake from Tata Sons, TCL is positioned to capitalize on the projected 15-17% CAGR in the NBFC sector.

நடுநிலை தாக்கம் 5/10 ஒழுங்குமுறை

TATACAP: SEBI Settlement Order Received Regarding CRPS Issuance

Tata Capital Limited received a Settlement Order from SEBI regarding the issuance of unlisted Cumulative Redeemable Preference Shares (CRPSs). The company filed a settlement application after it was found that CRPSs were down sold to more than 200 investors within six months of allotment, which was deemed a public issue. Tata Capital paid a settlement amount of ₹14,40,000. According to the company, this settlement order does not have a material financial implication.

நேர்மறை தாக்கம் 8/10 M&A

Tata Communications acquires 51% stake in Commotion, Inc. for $25.5M

Tata Communications, through its subsidiary TCNL, is acquiring a 51% stake in Commotion, Inc. for approximately $25.50 million (~₹227 Crores). This includes ~$15.50 million for stock purchase and ~$10.00 million as capital contribution. Commotion, Inc. had a revenue of USD 118,750 (~₹1.06 Crores) for the 12 months ended December 31, 2024. The acquisition aims to strengthen Tata Communications’ Customer Interaction Suite with AI capabilities.

நடுநிலை தாக்கம் 5/10 ஒழுங்குமுறை

CARE reaffirms Tata Chemicals' ₹1,700 crore NCD rating at AA+; Stable

CARE Ratings has reaffirmed the credit ratings for Tata Chemicals Limited. The rating for Non-Convertible Debentures (NCDs) worth ₹1,700 crore is reaffirmed at CARE AA+; Stable. Long Term Bank Facilities worth ₹1,300 crore also have a reaffirmed rating of CARE AA+; Stable. Short Term Bank Facilities worth ₹2,000 crore retain the CARE A1+ rating. A new Non-Convertible Debenture (NCD) of ₹1,500 crore has been assigned a CARE AA+; Stable rating.

⚠️ இந்தத் தளம் எவ்வாறு உருவாக்கப்படுகிறது: சந்தைத் தரவுப் பக்கங்கள் NSE/BSE வெளியீடுகள் மற்றும் நிறுவனங்களின் தாக்கல்களிலிருந்து தானாகக் கணக்கிடப்படுகின்றன; செய்திக் கட்டுரைகளும் அறிவிப்புப் பகுப்பாய்வுகளும் AI உதவியுடன் எழுதப்படுகின்றன, மனித மேற்பார்வையுடன்: AI உருவாக்குவதை எங்கள் ஆசிரியர்கள் மதிப்பாய்வு செய்கின்றனர். இரண்டிலும் பிழைகள் இருக்கலாம். எந்தவொரு முதலீட்டு முடிவுக்கு முன்பும் அசல் மூலங்களில் சரிபார்க்கவும். முதலீட்டு ஆலோசனை அல்ல; Flash Finance SEBI-பதிவு பெற்றது அல்ல. நாங்கள் AI-ஐ எவ்வாறு பயன்படுத்துகிறோம்